机构:[1]Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China大德路总院肿瘤科广东省中医院[2]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou 510120, China[3]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120, China广东省中医院
Abstract: Objective: To investigate the effect of Chinese herbal medicine Polyphyllin Ⅰ (PPⅠ) on the cell growth
inhibition of lung cancer and its molecular mechanisms. Methods: MTT, Wound healing assay and cell cycle assay were
performed to detect the effects of PPⅠ on the cell growth, migration and cell cycle of lung cancer. Western Blot analysis was used
to determine the protein expression of transcriptional regulator Sp1 and integrin-linked kinase ILK. qPCR analysis was used to
detect the expression of miR-542-3p and ILK mRNA. Overexpression plasmids or siRNAs of ILK and Sp1 were transfected by
using cell transient transfection technique. Dual-luciferase reporter assay was performed to measure the ILK promoter activity.
Results: The results showed that PPⅠ significantly inhibited the cell viability of A549 and PC9 cells in a time and dose dependent
manner. Western Blot results confirmed that PPⅠ down-regulated the expression of ILK protein. Silencing of ILK inhibited cell
viability and migration, and arrested the cell cycle in S phase. Conversely, overexpression of ILK promoted the cell viability and
reversed the growth inhibitory effect of PPⅠ on A549 and PC9 cells. miR-542-3p significantly suppressed the expression of ILK
protein through directly binding to the 3’-UTR of ILK mRNA. PPⅠ could effectively increase miR-542-3p expression a t the
same time. On the other hand, the protein expression of Sp1, a transcription regulated factor bound to ILK promoter region, was
significantly down-regulated by PPⅠ. Silencing of Sp1 inactivated the ILK promoter activity and decreased the expression of
ILK protein. Overexpression of Sp1 effectively reversed the effect of PPI-reduced expression of ILK protein. Conclusion: PPⅠ
significantly inhibited the cell growth of lung cancer by decreasing the ILK protein expression through increasing the level of miR-
542-3p and down-regulation of Sp1.
基金:
National Natural Science Foundation of China (No.81871863, No.81903991, No.81974543), Natural Science
Foundation of Guangdong Province (No.2020A1515010607, No.2021A1515410007), Guangzhou Science and Technology Plan
Project (No.202002030155, No.2020B1111100006), Postgraduate Research Innovation Project of Guangzhou University of
Chinese Medicine (No.A1-2606-21-429-001Z53)
语种:
外文
第一作者:
第一作者机构:[1]Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China[2]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou 510120, China
通讯作者:
通讯机构:[2]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou 510120, China[3]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120, China
推荐引用方式(GB/T 7714):
TANG Qing,WANG Su-mei,WU Wan-yin,et al.重楼皂苷ⅰ调控sp1/mir-542-3p/ilk信号通路对肺癌细胞的抑制作用[J].China Journal of Traditional Chinese Medicine and Pharmacy.2022,37(05):2805-2812.
APA:
TANG Qing,WANG Su-mei,WU Wan-yin&HAN Ling.(2022).重楼皂苷ⅰ调控sp1/mir-542-3p/ilk信号通路对肺癌细胞的抑制作用.China Journal of Traditional Chinese Medicine and Pharmacy,37,(05)
MLA:
TANG Qing,et al."重楼皂苷ⅰ调控sp1/mir-542-3p/ilk信号通路对肺癌细胞的抑制作用".China Journal of Traditional Chinese Medicine and Pharmacy 37..05(2022):2805-2812